Mount TAM Biotechnologies, Inc. (MNTM) financial statements (2021 and earlier)

Company profile

Business Address 7250 REDWOOD BLVD, SUITE 300
NOVATO, CA 94945
State of Incorp. NV
Fiscal Year End December 31
SIC 21 - Tobacco Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 584637553
Cash and cash equivalents 584637553
Receivables 300300   
Inventory, net of allowances, customer advances and progress billings     (5)
Inventory     (5)
Prepaid expense 544  
Other undisclosed current assets (300)(300)(0) 5
Total current assets: 625038053
Noncurrent Assets
Other undisclosed noncurrent assets 27   
Total noncurrent assets: 27   
TOTAL ASSETS: 645738053
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 852927603400170
Accounts payable 46445733527890
Accrued liabilities 9528314565 
Employee-related liabilities 2001309357 
Interest and dividends payable 933920  
Other undisclosed accounts payable and accrued liabilities 1189 80
Debt 1,332694181818
Due to related parties    254 
Total current liabilities: 2,1841,621620671187
Noncurrent Liabilities
Long-term debt and lease obligation   554  
Long-term debt, excluding current maturities   554  
Total noncurrent liabilities:   554  
Other undisclosed liabilities    115 
Total liabilities: 2,1841,6211,174786187
Stockholders' equity
Stockholders' equity attributable to parent, including: (2,120)(1,565)(794)(781)(185)
Common stock 65541
Common stock, share subscribed but unissued, subscriptions receivable (0)(0)(0)(0) 
Common stock, value, subscriptions   5843 
Additional paid in capital 6,8525,5803,6771,526775
Accumulated deficit (8,978)(7,150)(4,534)(2,353)(960)
Other undisclosed stockholders' equity attributable to parent (0)    
Total stockholders' equity: (2,120)(1,565)(794)(781)(185)
TOTAL LIABILITIES AND EQUITY: 645738053

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
Revenues  1  1
Revenue, net   1
Other income  1  
Cost of revenue
(Cost of Goods and Services Sold)
     (5)
Gross profit:  1  (5)
Operating expenses (1,817)(2,531)(2,079)(2,087)(146)
Other operating expense, net
(Other Expenses)
    (8) 
Other undisclosed operating loss  (1)   
Operating loss: (1,817)(2,531)(2,079)(2,095)(150)
Interest and debt expense (55)(19)(14)(66)(0)
Loss from continuing operations before equity method investments, income taxes: (1,871)(2,550)(2,093)(2,161)(150)
Other undisclosed income from continuing operations before income taxes 44    
Loss before gain (loss) on sale of properties: (1,828)(2,550)(2,093)(2,161)(150)
Other undisclosed net loss  (66)(87)  
Net loss: (1,828)(2,616)(2,181)(2,161)(150)
Other undisclosed net income attributable to parent    66 
Net loss available to common stockholders, diluted: (1,828)(2,616)(2,181)(2,095)(150)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
Net loss: (1,828)(2,616)(2,181)(2,161)(150)
Comprehensive loss, net of tax, attributable to parent: (1,828)(2,616)(2,181)(2,161)(150)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: